Literature DB >> 10214691

Proteases of protozoan parasites.

P J Rosenthal1.   

Abstract

Proteolytic enzymes seem to play important roles in the life cycles of all medically important protozoan parasites, including the organisms that cause malaria, trypanosomiasis, leishmaniasis, amebiasis, toxoplasmosis, giardiasis, cryptosporidiosis and trichomoniasis. Proteases from all four major proteolytic classes are utilized by protozoans for diverse functions, including the invasion of host cells and tissues, the degradation of mediators of the immune response and the hydrolysis of host proteins for nutritional purposes. The biochemical and molecular characterization of protozoan proteases is providing tools to improve our understanding of the functions of these enzymes. In addition, studies in multiple systems suggest that inhibitors of protozoan proteases have potent antiparasitic effects. This review will discuss recent advances in the identification and characterization of protozoan proteases, in the determination of the function of these enzymes, and in the evaluation of protease inhibitors as potential antiprotozoan drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214691     DOI: 10.1016/s0065-308x(08)60242-0

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  25 in total

1.  Anti-toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro.

Authors:  F Derouin; M Santillana-Hayat
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells.

Authors:  Manoj K Puthia; Selena W S Sio; Jia Lu; Kevin S W Tan
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria.

Authors:  Katherine T Andrews; David P Fairlie; Praveen K Madala; John Ray; David M Wyatt; Petrina M Hilton; Lewis A Melville; Lynette Beattie; Donald L Gardiner; Robert C Reid; Martin J Stoermer; Tina Skinner-Adams; Colin Berry; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa.

Authors:  Elizabeth L Ponder; Matthew Bogyo
Journal:  Eukaryot Cell       Date:  2007-09-28

Review 5.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

6.  Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

Authors:  Jane Xu Kelly; Rolf Winter; David H Peyton; David J Hinrichs; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

7.  Classico-molecular targeting of oligopeptidase B, cysteine protease and variable surface glycoprotein (VSG) genes of Trypanosoma evansi.

Authors:  Ruchi Singh Gaur; Vikrant Sudan; Amit Kumar Jaiswal; Amit Singh; Daya Shanker
Journal:  J Parasit Dis       Date:  2016-03-16

8.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

9.  Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani.

Authors:  Rajdeep Choudhury; Siddhartha Kumar Bhaumik; Tripti De; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2008-06-29       Impact factor: 3.396

Review 10.  Immunological and therapeutic strategies against salmonid cryptobiosis.

Authors:  Patrick T K Woo
Journal:  J Biomed Biotechnol       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.